Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04296578 | Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone | withdrawn | Phase 1 | 0 | Stanford UniversityOTHER | 0 | Aug 12, 2021 | clinicaltrials |
| NCT02108613 | Living Well on Androgen Deprivation Therapy | withdrawn | N/A | 0 | British Columbia Cancer AgencyOTHER | 1 | Jul 29, 2021 | clinicaltrials |
| NCT04486846 |
| Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth) |
| withdrawn |
| N/A |
| 0 |
| Duke UniversityOTHER |
| 1 |
| Jun 10, 2021 |
| clinicaltrials |
| NCT01802307 | Focal Therapy for Prostate Cancer | withdrawn | Phase 2 | 0 | University of Maryland, BaltimoreOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT01566045 | MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer | withdrawn | N/A | 0 | Philips HealthcareINDUSTRY | 1 | Apr 28, 2021 | clinicaltrials |
| NCT00621413 | Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer | withdrawn | — | 0 | IsoRay Medical, Inc.INDUSTRY | 1 | Apr 19, 2021 | clinicaltrials |
| NCT02497638 | LIpitor and biGuanide to Androgen Delay Trial(LIGAND) | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT03589781 | Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate | withdrawn | N/A | 0 | Nikkei (Canada) Marketing LimitedINDUSTRY | 1 | Mar 30, 2021 | clinicaltrials |
| NCT02295163 | Stellate Ganglion Block for Hot Flushes in Men Treated With ADT | withdrawn | N/A | 0 | Rijnstate HospitalOTHER | 1 | Mar 10, 2021 | clinicaltrials |
| NCT04585932 | Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04027270 | Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing Prostatectomy | withdrawn | N/A | 0 | University of Missouri-ColumbiaOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03563352 | Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer | withdrawn | — | 0 | University of Southern CaliforniaOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT03308734 | Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate Cancer | withdrawn | N/A | 0 | University of BathOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT01691976 | Mild Cognitive Impairment in Men Following Androgen Deprivation | withdrawn | N/A | 0 | Imperial College LondonOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT04225299 | Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer | withdrawn | Phase 3 | 0 | Steba Biotech S.A.OTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT04399824 | Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 6, 2020 | clinicaltrials |
| NCT03110588 | Phase I Trial of PACE for Metastatic Prostate Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02822963 | Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate | withdrawn | — | 0 | National Cheng-Kung University HospitalOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT01079793 | Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery | withdrawn | Phase 1 / Phase 2 | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT03488810 | Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer(ARN-509) | withdrawn | Phase 3 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Aug 17, 2020 | clinicaltrials |
| NCT01859689 | Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer | withdrawn | Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Jul 27, 2020 | clinicaltrials |
| NCT02597894 | Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 24, 2020 | clinicaltrials |
| NCT03596710 | Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Jul 23, 2020 | clinicaltrials |
| NCT04272645 | Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 15, 2020 | clinicaltrials |
| NCT03748719 | Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer | withdrawn | N/A | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | May 22, 2020 | clinicaltrials |
| NCT01766869 | Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS(GCC 1261) | withdrawn | — | 0 | University of Maryland, BaltimoreOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT03817216 | Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate Cancer | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Mar 12, 2020 | clinicaltrials |
| NCT02811809 | Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Feb 27, 2020 | clinicaltrials |
| NCT03293602 | MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET Imaging(MISOBOLD) | withdrawn | N/A | 0 | University Hospital, BordeauxOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT00980993 | Quantification of Respiratory-induced Prostate Motion | withdrawn | — | 0 | Oregon Health and Science UniversityOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT02538432 | Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors | withdrawn | Phase 2 | 0 | University of Maryland, BaltimoreOTHER | 0 | Nov 4, 2019 | clinicaltrials |
| NCT03408561 | Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT03514927 | High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Aug 22, 2019 | clinicaltrials |
| NCT03157947 | Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jul 5, 2019 | clinicaltrials |
| NCT02182622 | LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel | withdrawn | Phase 1 | 0 | Martin GutierrezOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT01811810 | Proton Therapy for High Risk Prostate Cancer | withdrawn | N/A | 0 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 23, 2019 | clinicaltrials |
| NCT00537849 | Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada | withdrawn | N/A | 0 | SonaCare MedicalINDUSTRY | 1 | Apr 10, 2019 | clinicaltrials |
| NCT02742259 | Validation of the Prostate Cancer Assay - Beta+Pivotal(VPCA-B+PIV) | withdrawn | — | 0 | Celsee DiagnosticsINDUSTRY | 0 | Mar 26, 2019 | clinicaltrials |
| NCT01275651 | Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole | withdrawn | — | 0 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 24, 2019 | clinicaltrials |
| NCT03147196 | Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery | withdrawn | Phase 2 | 0 | Mayo ClinicOTHER | 0 | Jan 22, 2019 | clinicaltrials |
| NCT00963300 | MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy | withdrawn | N/A | 0 | University of Texas Southwestern Medical CenterOTHER | 0 | Nov 26, 2018 | clinicaltrials |
| NCT03296124 | Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)(PRX32) | withdrawn | — | 0 | University of FloridaOTHER | 1 | Nov 16, 2018 | clinicaltrials |
| NCT03014973 | Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status(HORM) | withdrawn | N/A | 0 | Hopital FochOTHER | 1 | Sep 13, 2018 | clinicaltrials |
| NCT00562341 | Effect of Lap-Band Induced Weight Loss on Serum PSA Levels | withdrawn | — | 0 | Maimonides Medical CenterOTHER | 1 | Aug 23, 2018 | clinicaltrials |
| NCT00922818 | Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy(RPP) | withdrawn | — | 0 | Maimonides Medical CenterOTHER | 1 | Aug 20, 2018 | clinicaltrials |
| NCT02179762 | Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer(EASE) | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Aug 9, 2018 | clinicaltrials |
| NCT03465345 | Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients | withdrawn | Phase 1 | 0 | Medical University of South CarolinaOTHER | 1 | Aug 3, 2018 | clinicaltrials |
| NCT02053311 | Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents | withdrawn | Phase 3 | 0 | Swiss Cancer InstituteOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT02252978 | Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy | withdrawn | Phase 2 | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT00996749 | Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Jul 3, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Aug 12, 2021source: clinicaltrials